Arkadios Wealth Advisors Bluebird Bio, Inc. Transaction History

Arkadios Wealth Advisors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 19, 2021	SELL	$11.24 - $21.0 $1,202 - $2,247	-107 Closed	0 $0
Q2 2021 Jul 28, 2021	BUY	$18.04 - $22.09 $198 - $242	11 Added 11.46%	107 $3,000
Q1 2021 Apr 26, 2021	SELL	$16.59 - $33.89 $16 - $33	-1 Reduced 1.03%	96 $2,000
Q4 2020 Feb 09, 2021	BUY	$27.5 - $37.92 $1,402 - $1,933	51 Added 110.87%	97 $4,000
Q3 2020 Nov 10, 2020	BUY	$34.44 - $43.75 $1,584 - $2,012	46 New	46 $2.58 Million

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $28.5M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Arkadios Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Arkadios Wealth Advisors with notifications on news.